Hilltop Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Hilltop Holdings's ARKG Position: Q4 2024 in Review
Hilltop Holdings sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 9,266 shares — an estimated $237K sold.
Hilltop Holdings first reported a position in ARKG in Q2 2020 and held it in 17 quarters. The position peaked at $1.17M in Q4 2020. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.
- Hilltop Holdings reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
- Hilltop Holdings sold 9,266 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $237K.
- Hilltop Holdings first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 17 quarters.
- Hilltop Holdings's ARK Genomic Revolution ETF position peaked at $1.17M in Q4 2020.
- 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.
Based on Hilltop Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.